HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luciano Adorini Selected Research

Ursodeoxycholic Acid (Urso)

1/2018A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis.
4/2015Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luciano Adorini Research Topics

Disease

22Inflammation (Inflammations)
12/2019 - 12/2002
14Autoimmune Diseases (Autoimmune Disease)
05/2009 - 01/2002
13Fibrosis (Cirrhosis)
01/2020 - 12/2009
8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2011 - 05/2002
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 01/2011
6Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
07/2012 - 06/2006
5Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2020 - 06/2009
5Insulin Resistance
12/2019 - 01/2013
5Non-alcoholic Fatty Liver Disease
01/2019 - 04/2013
5Atherosclerosis
10/2018 - 08/2011
5Proteinuria
01/2018 - 12/2009
5Prostatitis
09/2009 - 12/2006
4Type 2 Diabetes Mellitus (MODY)
01/2019 - 10/2010
4Obesity
01/2018 - 12/2009
4Hypogonadism (Hypergonadotropic Hypogonadism)
01/2014 - 07/2012
4Hypercalcemia (Milk Alkali Syndrome)
06/2010 - 05/2004
3Reperfusion Injury
04/2022 - 01/2018
3Dyslipidemias (Dyslipidemia)
01/2020 - 08/2011
3Disease Progression
01/2018 - 05/2002
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2018 - 11/2010
3Hypoxia (Hypoxemia)
01/2017 - 01/2012
3Hyperglycemia
08/2011 - 11/2010
3Neoplasms (Cancer)
11/2008 - 01/2006
2Metabolic Diseases (Metabolic Disease)
06/2022 - 10/2010
2Fatty Liver
06/2022 - 11/2018
2Liver Diseases (Liver Disease)
06/2022 - 10/2010
2Ischemia
04/2022 - 01/2018
2Hypercholesterolemia
01/2018 - 01/2018
2Kidney Diseases (Kidney Disease)
01/2017 - 01/2016
2Glucose Intolerance
01/2014 - 01/2011
2Colitis
04/2011 - 06/2010
2Rheumatoid Arthritis
01/2011 - 11/2004
2Breast Neoplasms (Breast Cancer)
11/2008 - 03/2007
2Carcinogenesis
11/2008 - 03/2007
2Psoriasis (Pustulosis Palmaris et Plantaris)
07/2007 - 06/2002
2Prostatic Neoplasms (Prostate Cancer)
03/2007 - 06/2006
2Pelvic Pain
02/2007 - 12/2006
2Hyperplasia
07/2005 - 02/2005
1Alcoholic Fatty Liver
06/2022
1Cholestasis
11/2021
1Intrahepatic Cholestasis of Pregnancy
01/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2020
1Hepatomegaly
12/2019

Drug/Important Bio-Agent (IBA)

18obeticholic acidIBA
04/2022 - 11/2010
14Calcitriol Receptors (Calcitriol Receptor)IBA
06/2010 - 06/2002
12Bile Acids and Salts (Bile Acids)IBA
06/2022 - 10/2010
106-ethyl-24-norcholane-3,7,23-triol-23 sulfateIBA
01/2020 - 10/2010
9LipidsIBA
12/2019 - 12/2009
9Insulin (Novolin)FDA Link
01/2018 - 01/2002
8LigandsIBA
06/2022 - 06/2002
76alpha-ethyl-23(S)-methylcholic acidIBA
06/2022 - 10/2011
7BXL628IBA
04/2009 - 02/2005
6Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2011
6Messenger RNA (mRNA)IBA
01/2019 - 10/2002
5AcidsIBA
11/2018 - 12/2009
5Interleukin-6 (Interleukin 6)IBA
01/2017 - 04/2009
5Vitamin DFDA LinkGeneric
01/2011 - 08/2004
5Calcitriol (Calcijex)FDA LinkGeneric
07/2007 - 10/2002
4G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2022 - 10/2010
4EnzymesIBA
11/2021 - 11/2010
4Hormones (Hormone)IBA
11/2017 - 04/2002
4CytokinesIBA
01/2017 - 02/2007
4Testosterone (Sustanon)FDA Link
10/2012 - 01/2012
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2010 - 06/2006
41,25-dihydroxyvitamin DIBA
06/2010 - 04/2002
4Interleukin-12 (IL 12)IBA
09/2009 - 05/2002
3Pharmaceutical PreparationsIBA
12/2019 - 01/2006
3Streptozocin (Streptozotocin)FDA Link
01/2018 - 11/2010
3Fatty Acids (Saturated Fatty Acids)IBA
01/2018 - 12/2009
3AndrogensIBA
07/2012 - 02/2005
3Interleukin-8 (Interleukin 8)IBA
01/2012 - 02/2007
3AutoantigensIBA
09/2009 - 05/2002
3rho-Associated KinasesIBA
04/2009 - 02/2007
3Peptides (Polypeptides)IBA
08/2007 - 05/2003
3ChemokinesIBA
02/2007 - 12/2002
2Matrix Metalloproteinases (MMPs)IBA
04/2022 - 01/2020
2Glucagon-Like Peptide 1 (GLP 1)IBA
01/2019 - 10/2010
2Proteins (Proteins, Gene)FDA Link
11/2018 - 02/2005
2Cholic AcidIBA
10/2018 - 07/2014
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2018 - 04/2015
2MonocrotalineIBA
11/2017 - 01/2017
2Bleomycin (Blenoxane)FDA LinkGeneric
11/2017 - 01/2017
2SteroidsIBA
11/2017 - 12/2006
2Alanine Transaminase (SGPT)IBA
04/2015 - 09/2013
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2014 - 10/2012
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2011 - 10/2010
2Dextrans (Dextran)FDA Link
04/2011 - 06/2010
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2011 - 06/2010
2NF-kappa B (NF-kB)IBA
04/2009 - 08/2004
2Cholecalciferol (Vitamin D3)FDA Link
11/2008 - 01/2006
2AntigensIBA
08/2005 - 11/2004
11- (4- (3- (hydroxyimino)- 3- (2- methylpyridin- 4- yl)- 1- o- tolylpropyl)phenyl)piperidine- 4- carboxylic acidIBA
06/2022
1ProgesteroneFDA LinkGeneric
11/2021
1Antifibrotic AgentsIBA
01/2020
1Nonesterified Fatty Acids (NEFA)IBA
01/2020
1Galectin 3 (LGALS3)IBA
12/2019
1Hematoxylin (Haematoxylon)IBA
12/2019
1Eosine Yellowish-(YS) (Eosin)IBA
12/2019
1LiraglutideFDA Link
12/2019

Therapy/Procedure

5Therapeutics
06/2022 - 02/2005